Dynamic comparison between Daan real-time PCR and Cobas TaqMan for quantification of HBV DNA levels in patients with CHB.
about
Rapid and quantitative detection of hepatitis B virusTelbivudine treatment started in early and middle pregnancy completely blocks HBV vertical transmissionIFN-CSP inhibiting hepatitis B virus in HepG2.2.15 cells involves JAK-STAT signal pathwayPredictors of sustained virologic response after discontinuation of nucleos(t)ide analog treatment for chronic hepatitis B.Health-related quality of life in patients with chronic hepatitis B during antiviral treatment and off-treatment.A noninvasive diagnostic model to assess nonalcoholic hepatic steatosis in patients with chronic hepatitis B.Diagnostic value of prothrombin induced by the absence of vitamin K or antagonist-II (PIVKA-II) for early stage HBV related hepatocellular carcinoma.Effectiveness of entecavir or telbivudine therapy in patients with chronic hepatitis B virus infection pre-treated with interferon compared with de novo therapy with entecavir and telbivudine.A novel method to produce armored double-stranded DNA by encapsulation of MS2 viral capsids.Predictors for advanced liver fibrosis in chronic hepatitis B virus infection with persistently normal or mildly elevated alanine aminotransferase.Serum hepatitis B core antibody levels predict HBeAg seroconversion in chronic hepatitis B patients with high viral load treated with nucleos(t)ide analogs.Risk factors for osteoporosis in liver cirrhosis patients measured by transient elastography.Intraperitoneal hypertension, a novel risk factor for sepsis-associated encephalopathy in sepsis mice.Risk factors associated with liver steatosis and fibrosis in chronic hepatitis B patient with component of metabolic syndrome.Decreased expression of peroxisome proliferator-activated receptor alpha indicates unfavorable outcomes in hepatocellular carcinoma.Risk factors associated with nonalcohol fatty liver disease and fibrosis among patients with type 2 diabetes mellitusEffectiveness of telbivudine antiviral treatment in patients with hepatitis B virus-associated glomerulonephritis: A 104-week pilot study
P2860
Q26852749-FAACE41C-107D-4737-A2F6-4FFF627159BCQ33560668-F1441B42-CD18-4B12-A577-DE1F8A765B04Q35230043-14818895-6667-4087-8A4C-F1BAE514D228Q35973806-8EE94757-D43A-402B-85DA-51E526744273Q37588038-F39CFB62-9EFE-41A3-BDEF-D5DAC355FAB8Q37632267-96034A39-FC2D-4023-A736-1D3B36958BEDQ40065752-2C1C3025-6E9E-465A-A366-5D3E73DBC047Q40179044-2AD9A1E9-3E97-4C4A-A690-BB0D87F89B29Q41733472-8213473A-E7CF-4386-A2C7-30337CC8892BQ47101714-FB231613-7C4C-4DE1-81A9-29AFFE5CB497Q54234628-F1108934-55EC-4B34-B334-F5D41DD59955Q54970133-FB5A5891-BA4E-424F-8C1E-AD527642DB33Q55022752-23783997-477B-45C1-813D-489A5D691B17Q55167357-01FCF395-2573-44D1-A716-E4BC0FD8C9E9Q55454154-A1D3ADBC-B519-45AB-AF3C-203C0AC6E99EQ58739563-81CD0BAA-50D3-4AEE-9FE6-A2809D00AA79Q58802114-4DAE6241-95AB-4072-B53D-B9EAD920D5FA
P2860
Dynamic comparison between Daan real-time PCR and Cobas TaqMan for quantification of HBV DNA levels in patients with CHB.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Dynamic comparison between Daa ...... A levels in patients with CHB.
@ast
Dynamic comparison between Daa ...... A levels in patients with CHB.
@en
type
label
Dynamic comparison between Daa ...... A levels in patients with CHB.
@ast
Dynamic comparison between Daa ...... A levels in patients with CHB.
@en
prefLabel
Dynamic comparison between Daa ...... A levels in patients with CHB.
@ast
Dynamic comparison between Daa ...... A levels in patients with CHB.
@en
P2093
P2860
P356
P1476
Dynamic comparison between Daa ...... NA levels in patients with CHB
@en
P2093
Fang-fang Lv
Ye-gui Jiang
Yong-hong Zhang
P2860
P2888
P356
10.1186/1471-2334-14-85
P50
P577
2014-02-14T00:00:00Z
P5875
P6179
1010835295